AmerisourceBergen Corp | ABC.USX
United States - USD

Stock Exchange: NYSE

Symbol: ABC

Sector: Healthcare

Industry: Medical Distribution

About AmerisourceBergen Corp

AmerisourceBergen Corporation sources and distributes pharmaceutical products. Its U.S. Healthcare Solutions segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. The company also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; and pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to customers in the companion animal and production animal markets, as well as demand-creating sales force services to manufacturer. In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. The company's International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; and distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers and hospitals primarily in Europe. This segments also provides specialty transportation and logistics services for the biopharmaceutical industry. The company was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.

AmerisourceBergen Corp Stats

Previous close:Daily change:
180.39-0.23%
52-Week High:52-Week Low:
194.79135.14
Market Cap:Beta:
36.1 Billion0.56

AmerisourceBergen Corp Key Financials

P/E Ratio:Revenues:Revenue Growth:Gross Margin:
21.922254.4 Billion11.50%3.38%
Dividend Yield:Net Income:Earnings Growth:Net Income Margin:
1.08%1.7 Billion22.40%0.66%
P/E Ratio:Revenues:
21.922254.4 Billion
Dividend Yield:Net Income:
1.08%1.7 Billion
Revenue Growth:Gross Margin:
11.50%3.38%
Earnings Growth:Net Income Margin:
22.40%0.66%
ParametersStocks Investing
Stock CurrencyUSD
Dividend PayingYes
Fractional SharesNo
Maximum Shares100 Shares
Tick value per 1 share0.01 USD
Trading Commission0%
Minimum Price Increment0.01
Limit and Stop Levels0.0
Negative balance protectionNo
Swap free days allowanceN/A
Own the underlying AssetNo
Platform symbolABC.USX
Disclaimer: This material is provided by third-party data sources as a general marketing communication for information purposes only and does not constitute an independent investment research. Nothing in this communication contains, or should be considered as containing, an investment advice or an investment recommendation or a solicitation for the purpose of buying or selling of any financial instrument. All information provided is gathered from reputable sources and any information containing an indication of past performance is not a guarantee or reliable indicator of future performance. Users acknowledge that any investment in CFDs and Physical Stocks products is characterized by a certain degree of uncertainty and that any investment of this nature involves a high level of risk for which the users are solely responsible and liable. We assume no liability for any loss arising from any investment made based on the information presented here.
High Risk Investment Warning: Contracts for Difference (‘CFDs’) are complex financial products that are traded on margin. Trading CFDs carries a high degree of risk. It is possible to lose all your capital. These products may not be suitable for everyone and you should ensure that you understand the risks involved. Seek independent expert advice if necessary and speculate only with funds that you can afford to lose. Please think carefully whether such trading suits you, taking into consideration all the relevant circumstances as well as your personal resources. We do not recommend clients posting their entire account balance to meet margin requirements. Clients can minimise their level of exposure by requesting a change in leverage limit. For more information please refer to HYCM’s Risk Disclosure.
Disclaimer: The content of this page is for information purposes only and it is not intended as a recommendation or advice. Any indication of past performance or simulated past performance included in advertisements published by HYCM is not a reliable indicator of future results. The customer carries the sole responsibility for all the businesses or investments that are carried out at HYCM.
Regional Restrictions: We do not offer our services to residents of certain jurisdictions such as Afghanistan, Belgium, Hong Kong, the United States of America and some other regions. For more information please refer to our
Help Center

HYCM Limited is authorized and regulated under the Dubai Financial Services Authority with license number F000048.

Copyright © 2024 HYCM.